Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing
They begin to suffer from anemia, nerve damage, and other problems
Read full profile
They both are USP meaning they have an official monograph or documentation by the United States Pharmacopeia, both are not used for IV solutions
US$ 23.02
US$ 21.21
US$ 26.24
US$ 28.82
US$ 20.27
